- Home
- EDTK vs NVNO Comparison
EDTK vs NVNO Comparison
Compare EDTK & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDTK
- NVNO
- Stock Information
- Founded
- EDTK 2013
- NVNO 1987
- Country
- EDTK China
- NVNO United States
- Employees
- EDTK 28
- NVNO N/A
- Industry
- EDTK Other Consumer Services
- NVNO Medical/Dental Instruments
- Sector
- EDTK Real Estate
- NVNO Health Care
- Exchange
- EDTK Nasdaq
- NVNO Nasdaq
- Market Cap
- EDTK 17.7M
- NVNO 16.7M
- IPO Year
- EDTK 2020
- NVNO N/A
- Fundamental
- Price
- EDTK $1.06
- NVNO $0.95
- Analyst Decision
- EDTK
- NVNO
- Analyst Count
- EDTK 0
- NVNO 0
- Target Price
- EDTK N/A
- NVNO N/A
- AVG Volume (30 Days)
- EDTK 11.0K
- NVNO 686.9K
- Earning Date
- EDTK 08-08-2025
- NVNO 10-30-2025
- Dividend Yield
- EDTK N/A
- NVNO N/A
- EPS Growth
- EDTK N/A
- NVNO N/A
- EPS
- EDTK N/A
- NVNO N/A
- Revenue
- EDTK $893,690.00
- NVNO N/A
- Revenue This Year
- EDTK N/A
- NVNO N/A
- Revenue Next Year
- EDTK N/A
- NVNO N/A
- P/E Ratio
- EDTK N/A
- NVNO N/A
- Revenue Growth
- EDTK N/A
- NVNO N/A
- 52 Week Low
- EDTK $0.80
- NVNO $0.67
- 52 Week High
- EDTK $1.20
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- EDTK 48.86
- NVNO 33.87
- Support Level
- EDTK $1.07
- NVNO $0.85
- Resistance Level
- EDTK $1.14
- NVNO $0.99
- Average True Range (ATR)
- EDTK 0.04
- NVNO 0.06
- MACD
- EDTK -0.00
- NVNO 0.10
- Stochastic Oscillator
- EDTK 20.00
- NVNO 60.37
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.